Open AccessThe Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1
Author(s) -
Elena Jovanovska Janeva,
Zlatica Goseva,
Angjelko Gjorchev,
Angela Debreslioska,
Мирко Спироски,
Beti Zafirova,
Magdalena Genadieva Dimitrovа
Publication year - 2015
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2015.053
Subject(s) - medicine , montelukast , asthma , gastroenterology , combination therapy , anesthesia
IL-13 is one of many cytokines responsible for the chronic inflammation of asthma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom